Ask AI
Beyond Basics in Atopic Dermatitis Webcast

CE / CME

Beyond Basics in Atopic Dermatitis Care: Are You Behind the Curve With Advanced Biologics for Moderate to Severe Disease?

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: July 07, 2025

Expiration: July 06, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Case Study: Jacob, 19 Yr Old



  • History

    • AD diagnosed in early childhood, worsened at age 15

    • Other PMH: No significant health history



  • Social history

    • Missed many days of school; when at school, difficulty concentrating and had tough time completing his projects

    • Unable to exercise due to fatigue and increased flares from sweating



  • Physical examination

    • Generalized xerosis, eczema around face, neck and hands

    • Red, crusted hyperpigmented patches

    • SCORAD score: 48

    • ADCT: 18



  • Current medications

    • Topical corticosteroids, several courses of oral steroids and emollients

    • Prior phototherapy without much improvement  



Based on Jacob’s clinical presentation, what would be the most appropriate next step in management AD?

2.

Case Study: Sara, 13 Yr Old



  • Current presentation

    • Struggling with intense itching, widespread lesions, and poor quality of life

    • Disturbed sleep due to persistent itch

    • PMH: asthma



  • Social history

    • Unable to socialize and feels shy to play with her friends

    • Struggles to concentrate at school



  • Laboratory results

    • IgE: 2300 IU/mL

    • Eosinophils: 9.0%

    • CBC and LFTs: WNL

    • TB, hepatitis B and C screening: negative



  • Physical examination

    • Very dry skin with constant itch

    • Several infected areas, complaints that “everything stings”

    • SCORAD score: 43

    • ADCT: 17



  • Current medications

    • Topical corticosteroids and systemic corticosteroids for severe flares and phototherapy; adherent to therapy

    • Dermatologist is considering a biologic therapy that targets IL-13



Considering Sara’s clinical presentation and history, which of the following factors most strongly supports initiating an IL-13–targeting biologic therapy for her atopic dermatitis?

3.

When assessing a patient’s candidacy for advanced biologic therapy targeting IL-13 in AD, which factor(s) is the most indicative of the need for treatment escalation? Select all that apply.